Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. The company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc. Show more
15110 N. Dallas Parkway, Dallas, TX, 75248, United States
Market Cap
5.506M
52 Wk Range
$0.16 - $2.88
Previous Close
$0.34
Open
$0.32
Volume
483,234
Day Range
$0.32 - $0.38
Enterprise Value
4.327M
Cash
1.486M
Avg Qtr Burn
-1.078M
Insider Ownership
10.02%
Institutional Own.
14.95%
Qtr Updated
12/31/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
